Glycemic Index |

InSea2® is an extract obtained from brown algae Fucus vesiculosusandAscophyllum nodosum, produced by canadian company InnoVactiv.

It is an ingredient produced by aqueous extraction and standardized in polyphenols (mainly phlorotannins) at NLT 20%.

InSea2® has been evaluated in several in-vitro, in-vivo and clinical studies in which a significant effect has been observed towards reduction of glycemic and insulinemic post-prandial peak by administration of InSea2® right before a glucose load. In addition long terms effects on fasting glycemia and glycated heamoglobin levels have been detected.

Mechanism of action includes a reversible block by brown algae polyphenols towards those intestinal enzymes, such as alpha-amylase and alpha-glucosidase, that are responsible for hydrolysis of diet starch and disaccharides into base glucose moieties; this activity slows down the digestion of complex carbohydrates and also absorption of glucose, inducing a reduced secretion of insulin  for the uptake of hematic sugar. Another effect is the reduction of hypoglycemia which follows the action of insulin; hypoglycemia often causes loss of attention and craving which can push for further food assumption out of main meals.



Iscrivetevi al nostro organo di informazione scientifica.

Compagnia Farmaceutica Milanese redige mensilmente in italiano e in inglese una newsletter scientifica apprezzata da migliaia di operatori del settore nel mondo. Iscrivetevi e scaricate i numeri già editi.

  • C.F.M. utilizza i dati personali al fine di inviare la Newsletter, rispondere alle tue richieste di risorse ed eseguire le tue richieste di contatto. In qualunque momento potrai revocare la tua scelta cliccando sull’opzione opt-out in calce alle comunicazioni ricevute. Puoi seguire questo link per ulteriori informazioni sulla nostra Privacy Policy